eCOA, eSource & Clinical Trials Market Size will Observe Substantial Growth by 2029
Verfasser: ashwani_kailiya on Monday, 13 January 2020The global eCOA, eSource & Clinical Trials Market study presents an all in all compilation of the historical, current and future outlook of the Market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each eCOA, eSource & Clinical Trials Market player in a comprehensive way. Further, the eCOA, eSource & Clinical Trials Market report emphasizes the adoption pattern of the eCOA, eSource & Clinical Trials across various industries.
The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials. Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, says the report.
In this eCOA, eSource & Clinical Trials market study, the following years are considered to project the market footprint: